RecallRadar

FDA Drug recall D-0293-2026

Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufacture…

On 2026-01-28 the FDA classified a Class II recall of Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufacture… by Graviti Pharmaceuticals Private, citing presence of Foreign Substance.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0293-2026
ClassificationClass II
Statusongoing
Initiated2026-01-10
Published2026-01-28
Last updated2026-09-13 11:52 UTC
CompanyGraviti Pharmaceuticals Private
DistributionUS

Product

Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.

Reason

Presence of Foreign Substance

Identifiers

ndc64980-562-01
ndc64980-562-10
ndc64980-563-01
ndc64980-563-10
ndc64980-564-01
ndc64980-564-50
code_infoLot# FUB125042G; Exp. 05/13/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0293-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.